Adverse Events Management During Albendazole Mass Drug Administration: A Pilot Study Experiences from A District of Andhra Pradesh, India
Author(s):
Ciddhavaduta Deepa Latha1*, Vivekanandan Kalaiselvan2, Nadithe Laxman Reddy3 and Raja Vikram Prasad4<br>
Focussed Surveillance of Albendazole Mass Drug Administration
This pilot study describes the field experiences of integrated approach of regional Adverse Drug Reactions monitoring centre (AMC) under Pharmacovigilance Programme of India (PvPI) and National de worming program in Nandyal district of Andhra Pradesh, India in adverse events monitoring associated with albendazole mass drug administration in school children. Though 2% of adverse events (AE) reported as non - serious in nature, found few gap areas in management of children those encountered with such adverse events. Therefore, necessary Standard Operating Procedures and risk management plan to be developed and healthcare workers trained accordingly to minimize the risk.
